SiPore

WIPO WIPO 2018

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark SiPore was filed as Word mark on 06/01/2018 at the World Intellectual Property Organization.

Trademark Details Last update: March 15, 2023

Trademark form Word mark
File reference 1434255
Countries Australia Israel Japan Philippines United States of America (USA)
Base trademark EU No. 017548314, December 1, 2017
Application date June 1, 2018
Expiration date June 1, 2028

Trademark owner

Cardellgatan 1
114 36 Stockholm
SE

Trademark representatives

Chapel Quarter, Mount Street GB

goods and services

05 Dietetic preparations adapted for medical use; dietetic substances adapted for medical use; pharmaceuticals and natural remedies; preparations for use in naturopathy; nutritional supplements; chemical preparations for medical purposes; pharmaceutical preparations; chemico-pharmaceutical preparations; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients
10 Surgical and medical devices; capsulated medical devices; medical devices for the treatment and/or prevention of obesity and being overweight and their related diseases, and/or for use in weight control; medical devices for prediabetes, diabetes and glycaemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients

Trademark history

Date Document number Area Entry
November 7, 2021 2021/48 Gaz PH RAW: Total Invalidation
July 16, 2020 2020/30 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 8, 2020 2020/28 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 3, 2020 2020/8 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 5, 2019 2019/49 Gaz JP Rejection
June 19, 2019 2019/25 Gaz AU Rejection
May 30, 2019 2019/23 Gaz IL Rejection
May 2, 2019 2019/19 Gaz Deletion
April 11, 2019 2019/15 Gaz PH Rejection
March 22, 2019 2019/16 Gaz CN Rejection
December 11, 2018 2019/3 Gaz EM RAW: Partial Ceasing Effect
December 4, 2018 2018/49 Gaz US Rejection
June 1, 2018 2018/44 Gaz EM Registration

ID: 141434255